Kingfa Science & Technology (India) Limited has announced its financial results for the second quarter ended September 30, 2025, showing improvements in both revenue and profitability.

Financial Highlights

The company reported a net profit of 411.44 crore rupees for Q2, representing a 10.4% increase from 372.58 crore rupees in the same period last year. Revenue from operations rose to 4,656.89 crore rupees, up 11.5% from 4,183.28 crore rupees year-over-year.

The company's EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) increased to 606.00 crore rupees from 558.00 crore rupees in the previous year, showing a growth of 8.6%. However, the EBITDA margin saw a slight decrease to 13.01% from 13.35% in the corresponding quarter of the previous year.

Operational Performance

Kingfa Science & Technology, which manufactures modified thermoplastic compounds, has maintained its position as a single reportable segment in accordance with Ind AS 108. The company's performance reflects the ongoing demand for its products in various industries.

Balance Sheet Strength

As of September 30, 2025, Kingfa Science & Technology reported total assets of 17,346.07 crore rupees, a significant increase from 11,556.18 crore rupees as of March 31, 2025. This growth in assets indicates the company's expansion and investment activities.

Cash Flow and Liquidity

The company's cash and cash equivalents stood at 1,692.48 crore rupees at the end of the quarter, showing a substantial improvement in liquidity compared to 234.80 crore rupees at the end of the previous fiscal year.

Management Commentary

The company's board of directors approved the unaudited financial results in their meeting held on November 12, 2025. The results were reviewed by the Audit Committee before being presented to the board.

Corporate Governance Update

In the same board meeting, Kingfa Science & Technology also approved changes to the composition of certain board committees and amended its Related Party Transactions Policy to align with recent regulatory changes.

The company continues to focus on its core business of modified thermoplastic compounds, with the financial results indicating resilience in a competitive market environment.

Kingfa Science & Technology (India) Limited , a leading player in the Indian manufacturing sector, has received a significant boost to its capital raising efforts. The company has secured in-principle approval from both the National Stock Exchange (NSE) and the Bombay Stock Exchange (BSE) for a substantial preferential share issue.

Key Details of the Share Issue

Regulatory Approvals

The company received approval letters from both major Indian stock exchanges:

• NSE approval: Letter number NSE/LIST/50485
• BSE approval: Letter number LOD/PREF/MV/FIP/907/2025-26

Shareholder Approval

Prior to receiving exchange approvals, Kingfa Science & Technology held an Extraordinary General Meeting (EGM) to seek shareholder consent for the preferential issue. The resolution was passed with overwhelming support:

Implications and Next Steps

This preferential issue represents a significant capital infusion for Kingfa Science & Technology (India) Limited. The successful approval from both exchanges and strong shareholder support indicates confidence in the company's growth prospects and financial strategy.

The funds raised through this issue are likely to strengthen the company's balance sheet and could potentially be used for expansion plans, debt reduction, or other strategic initiatives. However, the specific use of proceeds has not been detailed in the available information.

Investors and market watchers will be keen to observe how Kingfa Science & Technology utilizes this capital to drive growth and enhance shareholder value in the coming months.

As the company moves forward with the share allotment process, it will need to comply with all relevant SEBI regulations and exchange requirements to complete the preferential issue successfully.